Dr. Robert M. Brenner This is Me

Education

 View all 63 references Web References

1. 1. biz.yahoo.com

   biz.yahoo.com/bw/080519/200805 - [Cached]

   Published on: 5/19/2008   Last Visited: 5/19/2008

   AMAG Pharmaceuticals, Inc. Announces Appointment of Robert M. Brenner, M.D. as Senior Vice President of Medical AffairsAMAG Pharmaceuticals, Inc.
   ...
   Announces Appointment of Robert M. Brenner, M.D. as Senior Vice President of Medical AffairsMonday May 19, 4:02 pm ET
   
   CAMBRIDGE, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG - News) today announced the appointment of Robert M. Brenner, M.D. to the position of Senior Vice President of Medical Affairs.Dr. Brenner brings nearly a decade of clinical development and medical affairs experience to the Company, having served most recently as Executive Director and Global Renal Anemia Program Area Leader at Amgen Inc.Dr. Brenner will be responsible for the Company's medical affairs and nephrology clinical development activities.
   
   "Dr. Brenner's extensive knowledge and experience in building strong teams, working with different government agencies and his relationships with the nephrology community will be invaluable as we plan for the expected launch of ferumoxytol in the first quarter of 2009," commented Brian J.G. Pereira, MD, President and CEO of AMAG Pharmaceuticals, Inc.
   ...
   Prior to joining AMAG Pharmaceuticals, Dr. Brenner was at Amgen for nine years where he served in a variety of nephrology leadership roles both in clinical development and medical affairs.During his career at Amgen, Dr. Brenner contributed to the approval of new products, led the design of clinical trials, and was a key liaison to the nephrology community, professional societies and regulatory agencies.Dr. Brenner received his B.A. from Johns Hopkins University and his M.D. from Albert Einstein College of Medicine.He completed his medical residency in internal medicine at the Brigham and Women's Hospital in Boston and his fellowship in nephrology at Stanford University Medical Center.

2. 2. National Kidney Foundation: Newsroom

   www.kidney.org/news/newsroom/n - [Cached]

   Published on: 11/14/2006   Last Visited: 11/8/2007

   "Amgen is proud to be the principal sponsor of KEEP, which promises to further our joint mission to better understand and improve the lives of patients with CKD," said Robert M. Brenner, MD, Senior Director of Nephrology Medical Affairs, Amgen Inc.

3. 3. hospitalpharma.com | Press Release | Amgen's Commitment to Kidney Disease Underscored by 47 Data Presentations at AMerican Society of Nephrology's 40th Annual Meeting and Scientific Exposition

   www.hospitalpharma.com/PressRe - [Cached]

   Published on: 11/5/2007   Last Visited: 2/26/2008

   "Amgen is committed to advancing the treatment and understanding of kidney disease for the millions of patients around the world who suffer from the disease and the millions more who are at risk for it," said Robert M. Brenner, M.D., executive director, Nephrology Medical Affairs, Amgen "This commitment is evident in the scope and significance of the data we will present this week at ASN."